The Cigna Group and Business Roundtable Host Workforce Mental Health Summit
Cencora Cut to Neutral at BofA; Risks to Walgreens, Cigna Contracts Cited
Sector Update: Health Care Stocks Decline in Afternoon Trading
Cigna Group Is Maintained at Buy by Jefferies
Jefferies Maintains The Cigna Group(CI.US) With Buy Rating, Raises Target Price to $422
Jefferies analyst David Windley maintains $The Cigna Group(CI.US)$ with a buy rating, and adjusts the target price from $407 to $422.According to TipRanks data, the analyst has a success rate of 64.2%
Cigna's PBM Express Scripts Sues the FTC for Misleading Claims on the Industry in July Report
FTC in July Reported PBMs Steer Patients Away From Less Expensive Medicines -- WSJ
Cigna Sues FTC Over Agency's PBM Report -- WSJ
Cigna's Express Scripts Business Demands FTC Retract PBM Report -- WSJ
Express News | Express Scripts Sues US FTC, Seeks Order to Force Agency to Withdraw Drug Pricing Report - Court Document
Express News | Cigna : Jefferies Raises Target Price to $422 From $402
(CI) - Analyzing Cigna's Short Interest
Express News | The Cigna Group Announces Appearance at the Bernstein Healthcare 1:1 Forum
Express News | Cigna Healthcare Makes Virtual Care Even Easier and More Convenient With New E-Treatment Option From Mdlive
Cigna Healthcare Makes Virtual Care Even Easier and More Convenient With New E-Treatment Option From MDLIVE
Investors Expecting an Aggressive Fed Cut Are Getting Too 'Ahead of the Curve,' UBS CEO Says
UnitedHealth Follows Competitors, Replaces Humira With Lower-Cost Biosimilars
UnitedHealth Joins Cigna, CVS in Removing AbbVie's Humira From Formularies: Report
Cigna Group Price Target Maintained With a $400.00/Share by Cantor Fitzgerald
Here's How Much You Would Have Made Owning Cigna Stock In The Last 10 Years